Maksymiuk A W, Skinnider L F
Cancer Invest. 1985;3(5):427-33. doi: 10.3109/07357908509039803.
Cell preparations from 49 cases of lymphoid malignancy were cultured to determine optimal culture conditions (in semisolid media). Colony growth was obtained in the majority of cases (73%) using the combination of phorbol myristate acetate (PMA) and lymphocyte-conditioned medium (L-CM). Cell surface marker studies of plated cells in 36 cases identified 31 to be B-cell type, 1 to be T-cell type, and 4 null-cell type. The morphology and markers of harvested cells were similar to plated cells, suggesting proliferation of neoplastic cells predominantly. A relationship was found between the degree of colony growth and the clinical course of the disease in lymphomas but not in chronic lymphocytic leukemia (CLL). The use of PMA in combination with other mitogens deserves further investigation as a colony growth stimulator in hemopoietic malignancies.
对49例淋巴系统恶性肿瘤患者的细胞制剂进行培养,以确定(在半固体培养基中)最佳培养条件。使用佛波酯(PMA)和淋巴细胞条件培养基(L-CM)的组合,大多数病例(73%)获得了集落生长。对36例培养细胞进行的细胞表面标志物研究显示,31例为B细胞型,1例为T细胞型,4例为裸细胞型。收获细胞的形态和标志物与培养细胞相似,提示主要是肿瘤细胞增殖。在淋巴瘤中发现集落生长程度与疾病临床进程之间存在关联,但在慢性淋巴细胞白血病(CLL)中未发现这种关联。PMA与其他促细胞分裂剂联合使用作为造血系统恶性肿瘤的集落生长刺激剂值得进一步研究。